Director dealings

Trade date Director Volume / Price Trade value Trade type
25/10/2024 Rupert Howell 1,000 @ 603.00p £6,030.00 Buy
22/10/2024 Conrad Bona 2,305 @ 628.90p £14,496.15 Buy
12/01/2023 Chris Willford 6,666 @ 150.00p £9,999.00 Buy
10/01/2023 James Gregory 15,384 @ 130.00p £19,999.20 Buy
06/01/2023 Philip Machray 15,380 @ 130.00p £19,994.00 Buy
13/12/2022 Conrad Bona 12,837 @ 148.00p £18,998.76 Buy
13/12/2022 Conrad Bona 13,570 @ 140.00p £18,998.00 Buy
13/12/2022 Conrad Bona 12,837 @ 148.00p £18,998.76 Buy
13/12/2022 Conrad Bona 13,570 @ 140.00p £18,998.00 Buy
30/11/2021 John Kearon 100,000 @ 320.00p £320,000.00 Sell

Director shareholdings

Name Holding Percent
John Kearon 2,818,235 22.00%
Chris Willford 33,666 0.00%
Conrad Bona 28,712 0.00%
James Gregory 15,384 0.00%
Philip Machray 15,380 0.00%
Rupert Howell 11,000 0.00%
Sophie Tomkins 8,000 0.00%

Major shareholders

Institution name Holding Percent
John Kearon 2,818,235 22.20%
MEDIQON Group AG 700,000 5.50%
Kestrel Partners LLP 674,000 5.32%
Lombard Odier Asset Management (Europe) Limited 603,476 4.80%
Herald Investment Management Limited 580,111 4.60%
Ruffer LLP 570,000 4.50%
Octopus Investments Limited 550,000 4.33%
Stefan Barden 521,643 4.10%
Motley Fool Funds Trust 514,609 4.10%
University of Notre Dame du Lac 500,000 3.90%
Ennismore Fund Management Limited 437,276 3.50%